|
Most antihistamines cause some cognitive impairment.(Atopic Dermatitis)
Skin & Allergy News
|
September 1, 2008|
|
COPYRIGHT 2008 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.
(Hide copyright information)
Copyright
|
KYOTO, JAPAN -- Fexofenadine is the sole truly nonsedating antihistamine--and the only one that does not cause objectively measurable cognitive and psychomotor impairment at doses that are commonly used in clinical practice, said Dr. Kazuhiko Yanai.
Fexofenadine (Allegra) is the only antihistamine that doesn't permeate the blood-brain barrier and therefore cannot bind to CNS [histamine.sub.1] ([H.sub.1]) receptors, explained Dr. Yanai, professor of pharmacology at Tohoku University, Sendal (Japan), at an international investigative dermatology meeting.
He ...
|
Procyon Announces Receipt for Short Form Prospectus
Newspaper article from: CCNMatthews Newswire
; ...CCNMatthews - Feb. 22, 2006) - Procyon Biopharma Inc. (TSX:PBP) Not for...BUSINESS/FINANCIAL/HEALTH EDITORS Procyon Biopharma Inc., a biotechnology company...concurrent to the merger via acquisition of Procyon and Cellpep S.A. The short form prospectus...
|
|
Procyon Announces the Completion of the Acquisition of Cellpep S.A. and the Concurrent Private Placement.
Business Wire
; MONTREAL -- Procyon Biopharma Inc. ("Procyon") (TSX:PBP) - Procyon changes its corporate name to Ambrilia Biopharma Inc. - Ticker symbol PBP on the Toronto Stock Exchange to change to AMB on March 3, 2006 ATTENTION BUSINESS/FINANCIAL...
|
|
|
Procyon Announces the Completion of the Acquisition of Cellpep S.A. and the Concurrent Private Placement
Newspaper article from: CCNMatthews Newswire
; MONTREAL, QUEBEC--(CCNMatthews - March 1, 2006) - Procyon Biopharma Inc. ("Procyon") (TSX:PBP) -__ Procyon changes its corporate name to Ambrilia Biopharma Inc. -__ Ticker symbol PBP on the Toronto...
|
|
Procyon completes the acquisition of Bioxalis Medica Inc. and closes a concurrent financing of $ 3.5 M.
PR Newswire
; ...June 30 /PRNewswire-FirstCall/ -- Procyon Biopharma Inc. (TSX: PBP) today announced...acquisition of Bioxalis will bring to Procyon's pipeline an innovative technology...Dox which is 12 months from an IND. Procyon has acquired all of Bioxalis' outstanding...
|
|
|
Procyon and Cellpep to Merge Via Acquisition Creating a New Global Biopharmaceutical Company: Ambrilia Biopharma Inc.
Newspaper article from: CCNMatthews Newswire
; ...CCNMatthews - Jan. 19, 2006) - Procyon Biopharma Inc. (TSX:PBP) ATTENTION...Montreal with a regional office in France Procyon Biopharma Inc., a biotechnology company...definitive acquisition agreement under which Procyon has offered to acquire all of the outstanding...
|
|
|
Procyon Biopharma reports progress at annual meeting.
PR Newswire
; ...Special Shareholders' meeting today, Procyon Biopharma Inc. (TSX: PBP) reviewed...President and Chief Executive Officer of Procyon, indicated that the Company was moving...its lead compound for metastatic HRPC. Procyon also indicated that the Fibrostat(R...
|
|
|
Procyon Biopharma identifies novel PSP94 binding protein.
PR Newswire
; ...detection and prognosis of prostate cancer Procyon Biopharma Inc. (TSX:PBP) announced...binding protein, a crucial part of Procyon's assay development technology for prostate...previous peer-reviewed publication, Procyon's collaborating scientists demonstrated...
|
|
PROCYON CUTS JOBS, CLOSES LABS TO REDUCE CASH FLOW.(Procyon Biopharma Inc. )
Magazine article from: BIOWORLD Today
; ...Byline: Jennifer Boggs, Staff Writer Procyon Biopharma Inc. will cut a third of its...said Hans Mader, president and CEO of Procyon. "We all expected that the Phase IIb...C$12 million for our 2005 budget." Procyon reported Jan. 18 that Fibrostat, a topical...
|
|
|
Procyon appoints Jinzi J. Wu, Ph.D., as Vice-President, Preclinical and Basic Research.
PR Newswire
; TICKER: PBP (TSX) Procyon Biopharma Inc. (TSX: PBP) announced...preclinical and basic research programs at Procyon and he will be a member of both the...pleased that Dr. Wu has accepted to join Procyon. As our three near-term value drivers...
|
|
|
Wind Point Partners Forms Procyon Technologies, Inc., Acquires Scot, Incorporated and McCormick Selph, Inc.
PR Newswire
; ...Michigan, today announced that it has invested in Procyon Technologies, Inc. and that Procyon concurrently has completed its first two acquisitions...transactions is approximately $130 million. Procyon will focus on delivering highly engineered components...
|
Find more facts and information related to the
article "Most antihistamines cause some cognitive ..."
